Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-07-11-Speech-3-385"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20070711.32.3-385"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Madam President, the Commission and Council are right to remind us that the 2003 waiver was greeted in this House as a great breakthrough in terms of access to medicine, but I think we are right as a Parliament to remind the other two institutions that four years later, not a single drug has been supplied to a single patient. As others have said, the reasons for this are complex. It is partly because of the expense of utilising the waiver, it is partly because of the complexity of the mechanism itself and it is partly because of economic pressure put on certain countries by other countries and by big pharmaceutical companies.
The Commission is right to say that we cannot go back and renegotiate this waiver. It was a complex deal that was struck and we are not asking for that. What we are saying is that if we are to give our assent to this waiver, we want the Commission to commit itself to giving technical, financial and political support to developing countries in order to enable them to utilise the mechanism. The four points that Commissioner Rehn made were all very valid and welcome, but he has to go beyond those four points and make it clear that he will give the backing that the developing countries need to access medicines today, not in 10 or 20 years time."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples